Global Newsletter

Great Opportunity for Foreign Medical Device Manufacturers in Thailand

The growing population, prolonged lifespan of citizens and the demand for better healthcare has contributed significantly to the Medical Device Market in Thailand. In 2030, it is predicted that 25% of the population in Thailand will be over 60 years and thus give rise to the need of more elaborate healthcare services. It is also important to note that the number of foreign patients receiving treatment has reached 2.35 million people in 2014 and this number is expected to increase annually. Therefore, Thailand is now projecting itself as a Hub for Healthcare in ASEAN. With the government’s economic reform plan, Medical Devices will be prioritized as a target industry by offering a special incentive package.

Medical Device Control Division (MDCD) is a regulatory authority underneath Thai Food and Drug Administration (TFDA) established in June 1990, to control manufacturing, importing, selling and advertising of medical devices in Thailand. The classes of Medical Devices are categorized into 3 groups; Licenses Medical Devices (Class I), Notified Medical Devices (Class II), General Medical Devices (Class III).

Table 1: Classes of Medical Devices in Thailand

Class I Class II Class III
Licensed Medical Devices Notified Medical Devices General Medical Devices
Insulin Disposable syringes
Surgical Gloves
Blood Bags for human
HIV test kits for diagnostic
Contact lens
Physical Therapy devices
Alcohol Detector devices
Silicone Breast Implants
Methamphetamine Test Kits
Ophthalmic Viscosurgical device(OVD)
Breast Enhancer
Concentrate for haemodialysis
Other medical devices which are not licensed or Notified medical device

In Thailand, Class I devices are the most strictly regulated, which requires full data set for registration with the TFDA before selling or manufacturing. In contrast……

Full text & latest issue is found in the mail magazine “Global Newsletter”

The “Global Newsletter” provides the latest information pertaining to clinical trials in the Asian region, including timely updates from Local Health Authorities in the regions of coverage and medical advancements of interest.
To subscribe to the Asian Newsletter, please contact us via the following form.

Share :